Push to Add Weight-Loss Drugs to PBS Subsidy Scheme
Health Minister Mark Butler confirms a push to list drugs like Wegovy on the PBS, potentially saving thousands for Australians with obesity. Read the latest.
Health Minister Mark Butler confirms a push to list drugs like Wegovy on the PBS, potentially saving thousands for Australians with obesity. Read the latest.
BlueScope Steel's board has firmly rejected a $13 billion takeover bid from Kerry Stokes and US partner Steel Dynamics, calling it an undervalued and opportunistic move. The tussle for Australia's largest steelmaker continues.
BlueScope Steel has firmly rejected a joint $13 billion takeover offer from SGH and Steel Dynamics, calling it an attempt to buy the company 'on the cheap'. Read the full details.
Ryan Stokes lobs a $13bn takeover offer for BlueScope, potentially derailing its plan to acquire the struggling Whyalla Steelworks. We explain the high-stakes corporate battle.
SGH and Steel Dynamics propose splitting BlueScope's Australian and North American operations in a $13.2bn joint takeover. BlueScope's board is evaluating the $30-a-share offer.
Investment firms SGH and US-based Attestor Capital have launched a joint $1.3 billion takeover bid for BlueScope Steel's North American building products arm. Read the full story on the proposed deal.
A Townsville family's desperate fight for a lifesaving cancer drug is stalled by PBS bureaucracy. Their plea highlights systemic delays affecting patients across Australia. Read their story.
Millions of Australians will save on prescription costs as PBS co-payments drop to $31.60 from New Year's Day. Find out how the federal government's policy affects you.
A unique Perth industrial property, where liquid cocaine is legally made for surgery, has sold for a multi-million dollar sum. The pharmaceutical tenant remains. Read the exclusive details.
A Hells Angels sergeant-at-arms faces court after being arrested at Sydney International Airport, accused of breaching orders following a Maitland clubhouse 'takeover'. Read the latest on the police crackdown.
Forrestania Resources has declared its takeover offer for Kula Gold unconditional, clearing the path to create a consolidated gold explorer targeting production in 2026.
Kula Gold's drilling at the historic Mt Palmer mine in WA has returned spectacular high-grade gold results, confirming a large-scale 3km mineralised system. The project is now a key target amid a takeover bid. Read more.
Venus Metals fights QGold's takeover, revealing a gold royalty & Rox stake worth over $46M. Board urges shareholders to take no action. Read the full story.
Treasurer Jim Chalmers has pledged a decision by Christmas on Hanwha's bid for a 19.9% stake in Austal. The move, under FIRB scrutiny, could reshape Australia's naval shipbuilding landscape.
A Kambah mother fights for PBS reform so her sons with Crohn's can access biologics, a first-line treatment in other OECD nations, instead of 18 tablets daily. #Health #Crohns #Australia
Liquidators have won court approval to investigate Creso Pharma's former packagers as they pursue over $20 million owed to creditors. Get the full details on the legal pursuit.
Perseus Mining has launched a $21 million all-cash counterbid for Predictive Discovery, securing the target's endorsement. The move shakes up the West African gold exploration sector.
Mayne Pharma's stock plummeted 20% after the government removed key products from the PBS. Discover the full impact on investors and the pharmaceutical sector.
Venus Metals urges shareholders to reject QGold's 17-cent takeover offer, citing undervaluation of assets including Youanmi royalty and Rox Resources stake. Takeover bid runs until January 16.
Venus Metals urges shareholders to ignore QGold's 17-cent takeover offer, citing undervaluation of assets including Youanmi royalty and Rox Resources stake. Takeover bid runs until January 16.
BHP confirms it will not pursue a $100 billion takeover of Anglo American after preliminary discussions. Read the latest on this major mining sector development.
Treasurer Jim Chalmers blocks US firm's takeover of South Australian pharmaceutical company, citing national interest in healthcare security. Read the full details.
Treasurer Jim Chalmers addresses Japan's national security concerns about South Korea's Hanwha acquiring Australian shipbuilder Austal. Read the latest developments.
Dominique Roth battles rare CTX disease but the life-changing drug costs $500,000 annually. Her story highlights urgent need for PBS reforms to help Australians with rare conditions.
Japan formally voices security concerns to Australian Defence regarding South Korea's Hanwha bid for Austal. The move could impact regional defence partnerships.
Broadcasting legend Sandy Roberts celebrates as a $440,000 myeloma drug is added to the PBS, costing patients under $32. A game-changer for cancer treatment in Australia.
Japanese government expresses national security concerns as South Korea's Hanwha Group bids for Australian shipbuilder Austal. What this means for regional defence.
Alarming 400% increase in ADHD medication poisonings reported in Australia over past decade. Experts warn of growing prescription rates and accidental overdoses.
Australian pharmaceutical giant Mayne Pharma faces investor backlash as its controversial US licensing agreement continues to dominate trading, creating clear winners and losers on the ASX.
South Korea's defence powerhouse Hanwha Group remains in contention for a strategic investment in Australian shipbuilder Austal, potentially reshaping naval manufacturing in the region.